“We were really excited by B-Resorcinol’s potential,” said Sarah Hiddemann, Head of Product Development Face Care Eucerin. “But its effectiveness against hyperpigmentation hadn’t been widely tested.
So we began by conducting in vitro tests, where we applied B-Resorcinol to artificial skin models in our lab. What we found was impressive: the skin tone became visibly lighter, brighter and more even.”
The secret behind B-Resorcinol’s effectiveness lies in its ability to inhibit the skin’s production of melanin – the pigment that causes dark spots – at the source.
“Melanin production can only take place if it’s triggered by an enzyme called tyrosinase,” Sarah Hiddemann explained. “B-Resorcinol reduces tyrosinase activity – which therefore decreases melanin production and hyperpigmentation.” (in-vitro)